BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6500451)

  • 1. [Hemorheologic therapy in peripheral arterial occlusive disease].
    Kiesewetter H; Jung F
    Fortschr Med; 1984 Oct; 102(37):921-4. PubMed ID: 6500451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conservative drug therapy and walking exercise in stage IIb peripheral arterial occlusion disease.
    Kiesewetter H; Jung F; Blume J; Bulling B; Gerhards M
    Klin Wochenschr; 1986 Oct; 64(20):1061-9. PubMed ID: 2431197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Blood rheology in peripheral occlusive disease. Effects of hemodilution and pentoxifylline].
    Angelkort B
    Wien Med Wochenschr; 1986; 136 Spec No():29-35. PubMed ID: 3548089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hyper- or isovolemic hemodilution in patients with stage II peripheral arterial occlusive disease].
    Kiesewetter H; Jung F; Blume J; Spitzer S; Birk A
    Acta Med Austriaca; 1991; 18 Suppl 1():23-7. PubMed ID: 1719729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hemodilution in peripheral arterial occlusive disease--study comparing 3 different variants of hemodilution].
    Weidinger P; Bilek M; Tekusch A
    Vasa Suppl; 1990; 30():137-8. PubMed ID: 2075564
    [No Abstract]   [Full Text] [Related]  

  • 6. [Iso- and hypervolemic hemodilution with hydroxyethyl starch (HES 200/.05 10%) in patients with II b peripheral arterial occlusive disease].
    Kiesewetter H; Blume J; Jung F; Spitzer S; Gerhards M; Waldhausen P; Wenzel E
    Wien Med Wochenschr; 1989 Sep; 139(17):396-401. PubMed ID: 2480029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current therapy of peripheral arterial occlusive diseases in the aged].
    Schütz RM
    Z Gerontol; 1992; 25(2):101-4. PubMed ID: 1609537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic consequences of hemorheologic research].
    Ernst E
    Wien Med Wochenschr; 1989 Dec; 139(24):569-80. PubMed ID: 2696217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Overview of the most frequent clinical manifestations of peripheral arterial occlusive disease in the elderly, its diagnosis and stage-related therapy].
    Ebert D
    Z Arztl Fortbild Qualitatssich; 1997 Sep; 91(6):525-31. PubMed ID: 9441027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hypervolemic hemodilution with medium molecular-weight hydroxyethyl starch: effect of duration of administration on viscoelasticity of blood in IIa and IIb peripheral arterial occlusive disease].
    Költringer P; Langsteger W; Lind P; Klima G; Pierer G; Reisecker F; Eber O
    Acta Med Austriaca; 1991; 18 Suppl 1():45-7. PubMed ID: 1719731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normovolemic hemodilution in peripheral arterial disease.
    Rieger H; Köhler M; Schoop W; Schmid-Schönbein H
    Ann Clin Res; 1981; 13 Suppl 33():78-83. PubMed ID: 7342848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy from the hemorheologic viewpoint. 1: Hemodilution and defibrinogenation].
    Ernst E
    Fortschr Med; 1986 Jun; 104(21):423-6. PubMed ID: 3732982
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hemorheologic studies for evaluating microcirculation in patients with peripheral arterial circulatory disorders and diabetes mellitus].
    Sternitzky R; Hänsgen K; Podhaisky H; Frank I; Klare M; Preuss EG
    Z Gesamte Inn Med; 1986 Oct; 41(19):539-42. PubMed ID: 3811440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hemodilution in peripheral arterial occlusive disease].
    Becsi C; Wehofer D; Weidinger P
    Vasa Suppl; 1988; 26():113-5. PubMed ID: 2462284
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of peripheral arterial occlusive disorders with rheologically active measures].
    Turowski A; Schmidt HH; Sternitzky R
    Z Arztl Fortbild (Jena); 1987; 81(17):883-8. PubMed ID: 3439205
    [No Abstract]   [Full Text] [Related]  

  • 16. Hypervolemic hemodilution with or without venesection in peripheral arterial occlusive disease stage II.
    Kiesewetter H; Jung F; Birk A; Spitzer S
    Int Angiol; 1994 Mar; 13(1):1-4. PubMed ID: 8077790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypervolemic hemodilution with bloodletting in patients with peripheral arterial occlusive disease].
    Kiesewetter H; Blume HJ; Jung F; Bach R; Spitzer S; Leipnitz G; Schieffer H; Bette L; Wenzel E
    Vasa Suppl; 1988; 26():107-12. PubMed ID: 2462283
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hemodilution in patients with multiple morbidity and peripheral arterial occlusive disease].
    Kiesewetter H; Blume J; Jung F; Spitzer S; Bach R; Birk A; Schieffer H; Wenzel E
    Schweiz Med Wochenschr; 1989 Dec; 119(51):1862-7. PubMed ID: 2481883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Induced hemodilution as a new concept in the therapy of peripheral circulatory disorders].
    Rieger H
    Internist (Berl); 1982 Jul; 23(7):375-82. PubMed ID: 7049999
    [No Abstract]   [Full Text] [Related]  

  • 20. [Blood rheological changes and their clinical significance in chronic arterial obstructive disease].
    Sternitzky R; Seige K
    Z Gesamte Inn Med; 1983 Jan; 38(1):1-7. PubMed ID: 6342278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.